BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2496060)

  • 1. Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma.
    Ikeda S; Sumii H; Akiyama K; Watanabe S; Ito S; Inoue H; Takechi H; Tanabe G; Oda T
    Jpn J Cancer Res; 1989 Jan; 80(1):6-9. PubMed ID: 2496060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low level amplification of c-sis and c-myc in a spontaneous osteosarcoma model.
    Kochevar DT; Kochevar J; Garrett L
    Cancer Lett; 1990 Sep; 53(2-3):213-22. PubMed ID: 2208081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic amplification of the MYC gene in human osteosarcomas.
    Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
    Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of cellular oncogenes in human osteosarcomas transplanted into nude mice].
    Asano S; Yamashita T
    Nihon Seikeigeka Gakkai Zasshi; 1988 Mar; 62(3):231-42. PubMed ID: 3164747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene amplification in squamous cell carcinoma of the oral cavity.
    Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Sumegi J; Klein G; Deo MG
    Jpn J Cancer Res; 1989 May; 80(5):430-7. PubMed ID: 2502519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.
    Sturm SA; Strauss PG; Adolph S; Hameister H; Erfle V
    Cancer Res; 1990 Jul; 50(13):4146-53. PubMed ID: 2141296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the c-myc proto-oncogene in soft tissue sarcomas.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    Oncology; 1994; 51(1):13-7. PubMed ID: 8265096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
    Maillet MW; Robinson RA; Burgart LJ
    Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression.
    Gamberi G; Benassi MS; Bohling T; Ragazzini P; Molendini L; Sollazzo MR; Pompetti F; Merli M; Magagnoli G; Balladelli A; Picci P
    Oncology; 1998; 55(6):556-63. PubMed ID: 9778623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
    Pompetti F; Rizzo P; Simon RM; Freidlin B; Mew DJ; Pass HI; Picci P; Levine AS; Carbone M
    J Cell Biochem; 1996 Oct; 63(1):37-50. PubMed ID: 8891902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ; Robinson RA; Haddad SF; Moore SA
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer.
    Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myc Gene amplification in primary stomach cancer.
    Koda T; Matsushima S; Sasaki A; Danjo Y; Kakinuma M
    Jpn J Cancer Res; 1985 Jul; 76(7):551-4. PubMed ID: 2993214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors.
    Sauceda R; Ocadiz R; Gutierrez AL; Salcedo M; Ortega V; Figueroa HH; Gariglio P
    Brain Res; 1988 Apr; 427(2):123-32. PubMed ID: 2838125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line.
    Nardeux PC; Daya-Grosjean L; Landin RM; Andéol Y; Suàrez HG
    Biochem Biophys Res Commun; 1987 Jul; 146(2):395-402. PubMed ID: 3476115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
    Terrier P; Sheng ZM; Schlumberger M; Tubiana M; Caillou B; Travagli JP; Fragu P; Parmentier C; Riou G
    Br J Cancer; 1988 Jan; 57(1):43-7. PubMed ID: 3348948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 gene amplification in metastatic osteosarcoma.
    Ladanyi M; Cha C; Lewis R; Jhanwar SC; Huvos AG; Healey JH
    Cancer Res; 1993 Jan; 53(1):16-8. PubMed ID: 8416741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines.
    Isfort RJ; Cody DB; Lovell G; Doersen CJ
    Mol Carcinog; 1995 Nov; 14(3):170-8. PubMed ID: 7576109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.